# US 2025/0171493 A1 · Processes for synthesis of withanolides and withaferins and analogs thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0171493 A1
- Document ID: US20250171493A1
- Status: Published application
- Kind: A1
- Application number: 18/844,216
- Filed: 2023-03-06
- Published: 2025-05-29
- Earliest claimed: 2022-03-05
- Assignees: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Applicants: H. Lee Moffitt Cancer Center and Research Institute, Inc.
- Inventors: Justin Matthew LOPCHUK
- Web page: https://patentgrep.com/patent/US20250171493A1

## CPC

- C07J 17/00: Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide C07J19/00)
- C07J 71/001: {Oxiranes}
- C07J 7/002: {not substituted in position 16}
- C07J 9/00: Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
- C07J 33/002: {not condensed}
- C07J 51/00: Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
- C07J: STEROIDS (seco-steroids C07C)

## Abstract

The present disclosure provides processes for the synthesis of withanolides such as Withanolide A and Withanolide D.

## Claims

### Claim 1

A process for synthesizing Withanolide D having the structure
comprising treating a compound of Formula I
with a titanium alkoxide and tert-butyl hydroperoxide to provide Withanolide D.

### Claim 2 (depends on 1)

The process of claim 1, further comprising preparing the compound of Formula I by a process comprising treating a compound of Formula II
with selenium dioxide to provide the compound of Formula I.

### Claim 3

A process for synthesizing Withanolide A having the structure
comprising treating Withacoagin having the structure
with a titanium alkoxide and tert-butyl hydroperoxide to provide Withanolide A.

### Claim 4 (depends on 3)

The process of claim 3, further comprising preparing Withacoagin by a process comprising treating a compound of Formula II
with light irradiation in the presence of a photocatalyst and oxygen followed by treatment with a reductant to provide Withacoagin.

### Claim 5 (depends on 2)

The process of claim 2, further comprising preparing the compound of Formula II by a process comprising removing a protecting group PG from a compound of Formula III
to provide a compound of Formula II.

### Claim 6 (depends on 5)

The process of claim 5, further comprising preparing the compound of Formula III by a process comprising treating a compound of Formula IV
with an oxidant to provide the compound of Formula III.

### Claim 7 (depends on 6)

The process of claim 6, further comprising preparing the compound of Formula IV by a process comprising treating a compound of Formula V
with an oxidant followed by a base to provide the compound of Formula IV.

### Claim 8 (depends on 7)

The process of claim 7, further comprising preparing the compound of Formula V by a process comprising treating a compound of Formula VI
with 2-nitrophenyl selenocyanate in the presence of a phosphine to provide the compound of Formula V.

### Claim 9 (depends on 8)

The process of claim 8, further comprising preparing the compound of Formula VI by a process comprising treating a compound of Formula VII
with a compound of Formula VIII
which has been previously treated with an amide base to provide the compound of Formula VI.

### Claim 10 (depends on 9)

The process of claim 9, further comprising preparing the compound of Formula VII by a process comprising treating a compound of Formula IX
under reaction conditions suitable for conversion of the 1,3-dithiolane moiety in Formula IX into an aldehyde moiety to provide the compound of Formula VII.

### Claim 11 (depends on 10)

The process of claim 10, further comprising preparing the compound of Formula IX by a process comprising treating a compound of Formula X
with sodium borohydride in the presence of cerium trichloride to provide the compound of Formula IX.

### Claim 12 (depends on 11)

The process of claim 11, further comprising preparing the compound of Formula X by a process comprising treating a compound of Formula XI
with an alkoxide base to provide the compound of Formula X.

### Claim 13 (depends on 12)

The process of claim 12, further comprising preparing the compound of Formula XI by a process comprising treating a compound of Formula XII
with an amide base followed by treating with N-tert-butyl phenylsulfinimidoyl chloride to provide the compound of Formula XI.

### Claim 14 (depends on 13)

The process of claim 13, further comprising preparing the compound of Formula XII by a process comprising treating a compound of Formula XIII
under suitable reaction conditions for introduction of a protection group PG to provide the compound of Formula XII.

### Claim 15 (depends on 14)

The process of claim 14, further comprising preparing the compound of Formula XIII by a process comprising treating a compound of Formula XIV
with aluminum isopropoxide to provide the compound of Formula XIII.

### Claim 16 (depends on 15)

The process of claim 15, further comprising preparing the compound of Formula XIV by a process comprising treating Pregnenolone
with 1,3-dithiane that has been previously treated with an organolithium base to provide the compound of Formula XIV.

### Claim 17 (depends on 1)

Withanolide D prepared by a process of claim 1:

### Claim 18 (depends on 3)

Withanolide A prepared by a process of claim 3:

### Claim 19

A process of preparing a compound of Formula A
comprising treating Withanolide D
with cerium trichloride to provide the compound of Formula A.

### Claim 20

A process of preparing a compound of Formula B
comprising treating Withanolide D
under hydrogenation conditions to provide the compound of Formula B.

### Claim 21

A compound selected from:
or a pharmaceutically acceptable salt or derivative thereof.
